Fredy Geiger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fredy Geiger has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alexandra Steinemann-Inauen
Eye Clinic, University Hospital Basel, Switzerland
1 shared publication- Anahita Bajka
Department of Ophthalmology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
1 shared publication - Daniel Barthelmes
Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
1 shared publication - Marc Stahel
Department of Ophthalmology, University Hospital Zurich and University of Zurich
1 shared publication - Mario Damiano Toro
Eye Clinic, Department of Public Health, University of Naples Federico II, 80131 Naples, Italy
1 shared publication - Maximilian Robert Justus Wiest
Department of Ophthalmology, University Hospital Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 4 February 2026
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 243 (04) , 290-292
Progressive Bilateral Localised Amyloidosis of the Eyelids and Conjunctiva Four Years after MALT Lymphoma: A Case Report
Amyloidosis refers to a heterogeneous group of disorders characterized by the deposition of insoluble protein fibrils in various tissues, including the eyes and their adnexa. It can occur either systemically or locally and is classified based on the type of amyloid protein involved. To date, 42 different amyloid fibril proteins have been identified; however, not all are associated with ocular deposition [1]. Orbital and adnexal amyloidosis is rare and most commonly affects the eyelid, orbit, and conjunctiva. While it can be the initial manifestation of systemic involvement, most cases are localized with amyloid light-chain (AL) deposits being the most common, resulting from the accumulation of misfolded immunoglobulin light chains [2], [3]. Due to the heterogeneity of the disease and the limited literature available, the diagnosis and management of orbital and adnexal amyloidosis remain challenging. Received: 06 October 2025 Accepted: 02 December 2025 Article published online: 04 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 14, 70469 Stuttgart, Germany
- 4 February 2026
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 243 (04) , 290-292
Open AccessProgressive Bilateral Localised Amyloidosis of the Eyelids and Conjunctiva Four Years after MALT Lymphoma: A Case Report
Amyloidosis refers to a heterogeneous group of disorders characterized by the deposition of insoluble protein fibrils in various tissues, including the eyes and their adnexa. It can occur either systemically or locally and is classified based on the type of amyloid protein involved. To date, 42 different amyloid fibril proteins have been identified; however, not all are associated with ocular deposition [1]. Orbital and adnexal amyloidosis is rare and most commonly affects the eyelid, orbit, and conjunctiva. While it can be the initial manifestation of systemic involvement, most cases are localized with amyloid light-chain (AL) deposits being the most common, resulting from the accumulation of misfolded immunoglobulin light chains [2], [3]. Due to the heterogeneity of the disease and the limited literature available, the diagnosis and management of orbital and adnexal amyloidosis remain challenging. Received: 06 October 2025 Accepted: 02 December 2025 Article published online: 04 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 14, 70469 Stuttgart, Germany
- Open Access
- 11 February 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 1018-1028
Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging—A Retrospective Chart Review
Using multimodal imaging, the literature proposed the following risk factors for choroidal nevus growth into melanoma: increased tumor thickness, subretinal fluid, decreased visual acuity, presence of orange pigment, ultrasound acoustic hollowness, and increased tumor diameter. This study investigated the presence of the mentioned risk factors in choroidal nevi, choroidal melanomas, and indeterminate choroidal melanocytic lesions. This retrospective, single-center chart review assessed choroidal melanocytic tumors with multimodal imaging. We defined our primary outcome as the cumulative presence of mentioned risk factors. Further, we evaluated various optical coherence tomography (OCT), ultrasound, and autofluorescence findings. We analyzed 51 tumors from 49 patients during the period from April 2008 to June 2021. The median (IQR) age was 64.0 (56.0 to 70.5) years, with 23 of 49 (46.9%) patients being female. The follow-up time for all tumors was median (IQR) 25.0 (12.0 to 39.0) months. The choroidal nevi had a median (range) risk score of 0.0 (0.0 to 3.0), and the choroidal melanoma of 5.0 (3.0 to 6.0), with statistically significant different ratings (p < 0.001). Multimodal imaging creates a score that may help to distinguish choroidal nevi from choroidal melanomas objectively.
- 11 February 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 1018-1028
Open AccessAssessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging—A Retrospective Chart Review
Using multimodal imaging, the literature proposed the following risk factors for choroidal nevus growth into melanoma: increased tumor thickness, subretinal fluid, decreased visual acuity, presence of orange pigment, ultrasound acoustic hollowness, and increased tumor diameter. This study investigated the presence of the mentioned risk factors in choroidal nevi, choroidal melanomas, and indeterminate choroidal melanocytic lesions. This retrospective, single-center chart review assessed choroidal melanocytic tumors with multimodal imaging. We defined our primary outcome as the cumulative presence of mentioned risk factors. Further, we evaluated various optical coherence tomography (OCT), ultrasound, and autofluorescence findings. We analyzed 51 tumors from 49 patients during the period from April 2008 to June 2021. The median (IQR) age was 64.0 (56.0 to 70.5) years, with 23 of 49 (46.9%) patients being female. The follow-up time for all tumors was median (IQR) 25.0 (12.0 to 39.0) months. The choroidal nevi had a median (range) risk score of 0.0 (0.0 to 3.0), and the choroidal melanoma of 5.0 (3.0 to 6.0), with statistically significant different ratings (p < 0.001). Multimodal imaging creates a score that may help to distinguish choroidal nevi from choroidal melanomas objectively.